+499.5%
MRNA vs AME
+29.8%
+469.7%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | AME | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | +1.5% | -3.7% | -2.2% |
| 7D | +5.5% | +0.6% | +4.9% | +5.5% |
| 30D | +158.7% | -6.7% | +165.4% | +164.3% |
| 3M | +182.1% | +4.1% | +178.1% | +155.6% |
| 6M | +151.8% | +1.6% | +150.2% | +135.0% |
| YTD | +393.6% | +16.1% | +377.4% | +271.5% |
| 1Y | +499.5% | +27.3% | +472.1% | +302.7% |
| All | +499.5% | +29.8% | +469.7% | +302.7% |
Cumulative growth
Daily Returns
Daily percentage return beside AME.
Daily Out/Under-Performance
Portfolio return minus AME return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × AME return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded AME wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling